First-In-Human Phase 1 Study Of Ds-1062a In Patients With Advanced Solid Tumors.

Jacob M. Sands,Toshio Shimizu,Edward B. Garon,Jonathan Greenberg, Ferdinand M. Guevara,Rebecca Suk Heist,Fumiaki Kobayashi,Yutaka Noguchi,Daisuke Okajima,Naoyuki Tajima,Alexander I. Spira,Noboru Yamamoto,Aaron Elliott Lisberg

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用 16|浏览14

暂无评分

摘要

TPS2605Background: DS-1062a is a trophoblast cell-surface antigen 2 (TROP2)-targeting antibody drug conjugate. TROP2 is overexpressed in epithelial cancers, including non-small cell lung cancer (NS...

查看译文

关键词

advanced solid tumors,first-in-human

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要